Delcath slashes U.S. staff by 20% after FDA-panel disaster

Ryan McBride The Queensbury, NY-based company plans to fire 20% of its U.S. workforce to conserve cash and concentrate resources in Europe, where the company has CE mark clearance for ...

FDA clamps partial hold on Cell Therapeutics trial after patient dies

John Carroll Cell Therapeutics today announced that the FDA had put a partial clinical hold on its study of the experimental blood cancer drug tosedostat after the death of one of the ...

Teva’s ‘morning after’ pill sole drug allowed OTC, for now

Eric Palmer The court battle is over, the political fight is done and Teva Pharmaceutical Industries' Plan B One-Step is the designated "morning after" pill approved for ...

FDA probes long-acting Zyprexa safety after 2 patients die

Tracy Staton Two patients have died unexpectedly after their Zyprexa Relprevv injections, and the FDA is now investigating. The agency says the patients died three to four days after ...

Who wins after SCOTUS pay-for-delay decision? Lawyers

Tracy Staton The pay-for-delay ruling is in. That means legal experts and industry analysts are poring over the decision, trying to assess its consequences. Any consensus? By eschewing ...

Royalty’s $8B offer wilts after Elan prevails in blocking bid

Ryan McBride Royalty Pharma signed the death certificate on its $ 8 billion bid for biotech Elan, withdrawing its appeal of a decision from an Irish panel that blocked its ability ...

Amicus explores new deals after FDA forces a delay on Fabry drug app

Alok Saboo Shares of Amicus Therapeutics plunged this morning after the biotech alerted investors that the FDA had blocked a possible route to a near-term approval for its experimental ...

Access To The Morning After Pill Remains An Issue: Baruch Explains

esilverman Earlier this week, the Obama administration gave up its fight to block over-the-counter access to the newer, more popular version of the morning after pill called ...

Eli Lilly racks up another Alzheimer’s failure after BACE drug sparks safety fears

John Carroll FierceBiotech News

GSK probes sales tactics in China days after firing R&D chief there

Eric Palmer Novartis acknowledged this week it had terminated some sales execs in India as it probes unethical practices there, and now GlaxoSmithKline admits it is looking into whether ...

Obama Drops Bid To Block Wider Access To Morning After Pill

esilverman In an unexpected reversal, the Obama administration has decided it will no longer block over-the-counter access of any version of the Plan B morning after pill to ...

Police probe death after recall of mispackaged Teva drugs

Eric Palmer French authorities are investigating whether the death of a 92 year old man is tied to mispackaged furosemide. FiercePharma News
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS